HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population.

AbstractBACKGROUND:
Raf-1 kinase inhibitor protein (RKIP) plays a critical role in tumor development by regulating cell functions such as invasion, apoptosis and differentiation. Down-regulation of RKIP expression has been implicated in the development and progression of renal cell carcinoma (RCC). Herein, we hypothesized that genetic polymorphisms in RKIP might be associated with susceptibility and progression of RCC.
METHODS:
A total of 5 tagging single-nucleotide polymorphisms (tSNPs) in RKIP were selected and genotyped by SNapShot method in a case-control study of 859 RCC patients and 1004 controls. The logistic regression was used to evaluate the genetic association with occurrence and progression of RCC. The functionality of the important SNP was preliminary examined by qRT-PCR.
RESULT:
We found that the rs17512051 in the promoter region of RKIP was significantly associated with decreased clear cell RCC (ccRCC) risk (TA/AA vs. TT: P = 0.039, OR = 0.78, 95%CI = 0.62-0.99). Another SNP (rs1051470) in the 3'UTR region of RKIP was marginally associated with increased ccRCC risk (TT vs. CC+CT: OR = 1.45, 95%CI = 1.01-2.09). In the stratified analysis, the protective effect of rs17512051 was more predominant in the subgroups of male, non-smokers, non-drinkers as well as subjects without history of diabetes. Furthermore, we observed higher RKIP mRNA levels in the presence of the rs17512051A allele in normal renal tissues.
CONCLUSION:
Our results suggest that the potentially functional RKIP rs17512051 polymorphism may affect ccRCC susceptibility through altering the endogenous RKIP expression level. Risk effects and the functional impact of this polymorphism need further validation.
AuthorsQiang Cao, Jian Wang, Mingcong Zhang, Pu Li, Jian Qian, Shaobo Zhang, Lei Zhang, Xiaobing Ju, Meilin Wang, Zhengdong Zhang, Jie Li, Min Gu, Wei Zhang, Chao Qin, Pengfei Shao, Changjun Yin
JournalPloS one (PLoS One) Vol. 9 Issue 10 Pg. e109285 ( 2014) ISSN: 1932-6203 [Electronic] United States
PMID25329396 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphatidylethanolamine Binding Protein
Topics
  • Asian People (genetics)
  • Carcinoma, Renal Cell (genetics, pathology)
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease (genetics)
  • Humans
  • Male
  • Middle Aged
  • Phosphatidylethanolamine Binding Protein (genetics)
  • Polymorphism, Single Nucleotide

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: